influenza

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

News

CEPI steps in to fund Moderna's pandemic flu jab

Thanks to CEPI, Moderna's H5 bird flu vaccine can start a pivotal trial shelved after funding for the jab was pulled in the US by HHS Sec Kennedy.

News

Update: MSD's $9.2bn deal for flu biotech Cidara confirmed

MSD has signed a $9.2 billion takeover deal for Cidara that will bolt on a universal flu prevention candidate in phase 3.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Cidara gets $339m BARDA award for flu prophylactic

Cidara is celebrating a major injection of funding from the US government for its experimental one-shot, universal flu prophylactic CD388.

News

Sanofi faces EU antitrust probe into vaccine business

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

FDA seeks changes to GLP-1, flu shot labels

CEPI steps in to fund Moderna's pandemic flu jab

Update: MSD's $9.2bn deal for flu biotech Cidara confirmed

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Cidara gets $339m BARDA award for flu prophylactic

Sanofi faces EU antitrust probe into vaccine business

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

influenza

Editor's Picks